Insider Selling: Quantum-Si (NASDAQ:QSI) Insider Sells 21,927 Shares of Stock

Quantum-Si Incorporated (NASDAQ:QSI) insider John Vieceli sold 21,927 shares of the firm’s stock in a transaction on Monday, December 22nd. The stock was sold at an average price of $1.28, for a total value of $28,066.56. Following the transaction, the insider owned 800,973 shares of the company’s stock, valued at approximately $1,025,245.44. This represents a 2.66% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Quantum-Si Stock Performance

Shares of NASDAQ QSI remained flat at $1.27 during trading on Monday. The stock had a trading volume of 5,071,186 shares, compared to its average volume of 3,958,795. The stock has a market capitalization of $273.67 million, a P/E ratio of -1.90 and a beta of 2.97. Quantum-Si Incorporated has a twelve month low of $0.95 and a twelve month high of $5.77. The stock has a fifty day moving average price of $1.66 and a 200-day moving average price of $1.58.

Quantum-Si (NASDAQ:QSI) last announced its earnings results on Wednesday, November 5th. The company reported ($0.17) EPS for the quarter, meeting analysts’ consensus estimates of ($0.17). The company had revenue of $0.55 million during the quarter, compared to analysts’ expectations of $0.60 million. Quantum-Si had a negative return on equity of 47.90% and a negative net margin of 3,677.97%. Research analysts expect that Quantum-Si Incorporated will post -0.65 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Quantum-Si

Several hedge funds and other institutional investors have recently bought and sold shares of QSI. Nuveen LLC purchased a new stake in shares of Quantum-Si in the 1st quarter valued at about $383,000. Geode Capital Management LLC increased its position in Quantum-Si by 15.1% during the second quarter. Geode Capital Management LLC now owns 3,447,738 shares of the company’s stock worth $6,759,000 after buying an additional 452,850 shares in the last quarter. Russell Investments Group Ltd. increased its position in Quantum-Si by 322.6% during the 1st quarter. Russell Investments Group Ltd. now owns 38,257 shares of the company’s stock worth $46,000 after purchasing an additional 29,204 shares in the last quarter. Charles Schwab Investment Management Inc. raised its position in shares of Quantum-Si by 19.3% in the first quarter. Charles Schwab Investment Management Inc. now owns 367,444 shares of the company’s stock valued at $441,000 after buying an additional 59,423 shares during the last quarter. Finally, JTC Employer Solutions Trustee Ltd acquired a new stake in shares of Quantum-Si during the second quarter worth $26,000. 39.90% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages have commented on QSI. Canaccord Genuity Group dropped their price objective on shares of Quantum-Si from $2.00 to $1.50 and set a “hold” rating on the stock in a research report on Monday. Weiss Ratings reiterated a “sell (e+)” rating on shares of Quantum-Si in a research note on Monday, December 8th. Two analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $3.60.

Quantum-Si Company Profile

Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.

Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.